Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 37 citations
Electronic publication date
July 26, 2005

View on Pubmed.gov 15929184 | View on doi.org 10.3748/wjg.v11...

Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression.

Search for publications in this journal World J Gastroenterol - 11(21):3285-9

  • Dan Xie

    Search for this expert
    1
  • Jonathan-S-T Sham

    Search for this expert
  • Wei-Fen Zeng

    Search for this expert
  • Li-Hong Che
  • Meng Zhang

    Search for this expert
  • Hui-Xi Wu

    Search for this expert
  • Han-Liang Lin

    Search for this expert
  • Jian-Ming Wen
  • Sze-Hang Lau

    Search for this expert
  • Liang Hu
  • Xin-Yuan Guan

    Search for this expert

Abstract

AIM

To investigate the expression pattern of clusterin in colorectal adenoma-carcinoma-metastasis series, and to explore the potential role of clusterin in multistage colorectal tumorigenesis and progression.

METHODS

A colorectal carcinoma (CRC)-tissue microarray (TMA), which contained 85 advanced CRCs including 43 cases of Dukes B, 21 of Dukes C and 21 of Dukes D tumors, were used for assessing the expression of clusterin (clone 41D) and tumor cell apoptotic index (AI) by immunohistochemistry and TUNEL assay, respectively. Moreover the potential correlation of clusterin expression with the patient's clinical-pathological features were also examined.

RESULTS

The positive staining of clusterin in different colorectal tissues was primarily a cytoplasmic pattern. Cytoplasmic overexpression of clusterin was detected in none of the normal colorectal mucosa, 17% of the adenomas, 46% of the primary CRCs, and 57% of the CRC metastatic lesions. In addition, a significant positive correlation between overexpression of clusterin and advanced clinical (Dukes) stage was observed (P<0.01). Overexpression of cytoplasmic clusterin in CRCs was inversely correlated with tumor apoptotic index (P<0.01), indicating the anti-apoptotic function of cytoplasmic clusterin in CRCs.

CONCLUSION

These data suggests that overexpression of cytoplasmic clusterin might be involved in the tumorigenesis and/or progression of CRCs. The anti-apoptotic function of cytoplasmic clusterin may be responsible, at least in part, for the development and biologically aggressive behavior of CRC.

References

J Biol Chem. 2003 Mar 28;278(13):11590-600

Biochim Biophys Acta. 1996 Apr 24;1311(2):71-6

Int J Cancer. 1999 Nov 12;83(4):435-40

Int J Biochem Cell Biol. 2002 Nov;34(11):1430-48

Cited by 37 citations (total)

Journal Article

Association between clusterin polymorphisms and esophageal squamous cell carcinoma risk in Han Chinese population.

Electronic publication date November 10, 2015

Search for publications in this journal Int J Clin Exp Med

Kun Li [...] Guang-Hong Guo et al.

Genetic susceptibility plays an essential role in an individual's risk of esophageal squamous cell carcinoma (ESCC). The aim of this...

Journal Article Research Support, Non-U.S. Gov't

eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.

Electronic publication date February 15, 2017

Search for publications in this journal Oncotarget

Ji-Yeon Lee [...] Seung-Hoon Lee et al.

Clusterin is a secretory heterodimeric glycoprotein and the overexpression of secretory clusterin (sCLU) promotes cancer cell proliferation and reduces chemosensitivity....

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances